Trump’s executive order rejects quick fixes for sustainable solutions.

It hasn’t even been a week since President Donald J. Trump stepped into office, and the mass media is already in full attack mode. Armed with misleading headlines and cherry-picked narratives, the media is working overtime to paint Trump as a champion of Big Pharma, claiming his recent rescission of Biden’s Executive Order 14087 proves he’s prioritizing corporate interests over senior citizens. But as is often the case, the truth lies in the details the media conveniently omits.
Far from being an act of sabotage against affordable healthcare, Trump’s decision reflects a broader, more pragmatic strategy to fix America’s broken drug pricing system. The mainstream media, however, would rather use fear tactics than acknowledge the facts, preying on public emotions to fuel their agenda. It’s time to set the record straight on what this executive action truly means—and what it doesn’t.
A Closer Look at the Facts
On January 21, 2025, President Trump signed an executive order rescinding Biden’s EO 14087. This Biden-era directive sought to cap copayments for generic drugs at $2 and implement Medicaid pilot programs for cutting-edge treatments. On the surface, it sounds like a loss for seniors and low-income Americans, right? That’s exactly what the media wants you to believe. But here’s the truth they conveniently leave out: these programs were in pilot stages and not yet operational.
The media’s narrative fails to mention that Biden’s initiative was, at best, a patchwork experiment—not a fully implemented solution. Rescinding these plans doesn’t mean seniors are paying higher drug costs; it means Trump is pausing unproven, half-baked programs to pave the way for more comprehensive and sustainable reforms. The pilot programs Biden proposed never delivered the promised benefits—they were merely hypothetical scenarios, not tangible solutions.
Trump’s Plan: Reform, Not Ruin
Critics argue that this move signals a cozy relationship between Trump and Big Pharma, but let’s consider what the media won’t tell you. Trump’s approach isn’t about favoring pharmaceutical companies—it’s about rejecting government overreach and opting for a market-driven strategy. This administration believes in fostering industry competition, increasing transparency, and cutting out bureaucratic inefficiencies to lower drug prices for everyone.
The real story here isn’t what Trump has undone, but what he’s building. His administration is in its infancy, with appointments like Robert F. Kennedy Jr.—a staunch advocate for vaccine and pharmaceutical accountability—yet to be confirmed. It’s clear that meaningful reform is on the horizon, but true progress requires time and a stable foundation.
Media Manipulation: Distorting the Narrative
Rather than reporting the full story, liberal media outlets have launched a coordinated effort to sell Americans a distorted narrative: Trump is anti-senior and pro-Big Pharma. This is a textbook example of fear mongering and selective reporting. What they won’t admit is that the programs they’re lamenting were nothing more than political window dressing by the Biden administration—initiatives that sounded good but lacked the infrastructure to deliver real results.
The media’s willingness to prioritize sensationalism over substance reveals their true agenda: undermining Trump at every turn. Their deceptive tactics ignore critical context and promote half-truths to score political points, all while undermining the trust of the American people.
Conclusion: A Better Future Lies Ahead
President Trump’s decision to rescind EO 14087 isn’t the end of the road for affordable drug pricing—it’s the beginning of a more thoughtful, effective strategy.
This administration is committed to tearing down the corrupt, bureaucratic structures left by Biden and building a system that prioritizes innovation, transparency, and real results for American families.
The media wants you to believe that four days of policy changes define the next four years. Don’t be fooled. Trump’s presidency has just begun, and his record proves that he’s ready to fight for the American people—free from the corporate interests and political theater that defined the last administration. Trust the process, stay informed, and remember: the best is yet to come.
Comments